NCT00561717

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

A Four-Way Double-Blind, Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of Azelastine Nasal Spray and Antihistaminic Agents in Adult Subjects With Allergen Induced Seasonal Allergic Rhinitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Finding out how fast azelastine nasal spray works in subjects with hay fever.

Conditions

• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Azelastine and placebo	One Astelin spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.
DRUG	Loratadine and Placebo	One placebo spray per nostril plus one Loratadine 10 mg tablet. In Cross-Over-Design with other arms.
DRUG	Cetirizine and Placebo	One placebo spray per nostril plus one 10 mg Cetirizine tablet. In Cross-Over-Design with other arms.
DRUG	Placebo and Placebo (spray and Tablet)	One placebo spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.

Timeline

• Start date: 2007-10-01
• Primary completion: 2007-12-01
• Completion: 2008-02-01
• First posted: 2007-11-21
• Last updated: 2013-05-07

Locations

1 site across 1 country: Canada